Alimera Sciences Competitors and Similar CompaniesClear all

Alimera Sciences's competitors and similar companies include BeyondSpring and Biogen.
Alimera Sciences
Alimera Sciences
Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
BeyondSpring
BeyondSpring
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Biogen
Biogen
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
Founding Date
Founding Date
2003
Founding Date
2010
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Alpharetta, US HQ
Berlin, DE
Dublin 2, IE
Lisboa, PT
Hampshire, GB
Locations
Florham Park, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Employees
Employees
1222% decrease
Employees
4014% increase
Employees
7,605
Valuation ($)
Valuation ($)
301.3 m
Valuation ($)
89.4 m
Valuation ($)
26.7 b

Financial

Revenue (est.)
Revenue (est.)
$80.8m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$9.9b (FY, 2025)
Gross profit
Gross profit
$69.9m (FY, 2023)
Gross profit
N/A
Gross profit
$7.5b (FY, 2025)
Net income
Net income
($20.1m) (FY, 2023)
Net income
($16.7m) (FY, 2024)
Net income
$1.3b (FY, 2025)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2019)
Phase I Trials Products
4 (FY, 2024)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
6 (FY, 2024)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
3 (FY, 2019)
Phase III Trials Products
11 (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 232.6m
Total funding raised
$ 36.1m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

BeyondSpring
HQ
Florham Park, US
Employees
40↑ 14% increase

BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.

View company
Biogen
HQ
Cambridge, US
Employees
7,605

Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.

View company